Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioXcel Therapeutics (BTAI) Prepaid Assets (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Prepaid Assets data on record, last reported at $934000.0 in Q3 2025.

  • For Q3 2025, Prepaid Assets fell 79.15% year-over-year to $934000.0; the TTM value through Sep 2025 reached $934000.0, down 79.15%, while the annual FY2024 figure was $5.3 million, 90.15% up from the prior year.
  • Prepaid Assets reached $934000.0 in Q3 2025 per BTAI's latest filing, down from $5.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.5 million in Q3 2022 and bottomed at $934000.0 in Q3 2025.
  • Average Prepaid Assets over 4 years is $3.4 million, with a median of $3.7 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: soared 238.7% in 2023, then tumbled 79.15% in 2025.
  • A 4-year view of Prepaid Assets shows it stood at $3.1 million in 2022, then decreased by 9.29% to $2.8 million in 2023, then skyrocketed by 90.15% to $5.3 million in 2024, then tumbled by 82.34% to $934000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $934000.0 in Q3 2025, $5.1 million in Q2 2025, and $4.7 million in Q1 2025.